Dr Pam Kearns is a Clinical Senior Lecturer at the University of Birmingham and Honorary Consultant in Paediatric Oncology at the Birmingham Children’s Hospital. More recently, she has taken on the role of Deputy Director responsible for paediatric trials within the Cancer Research UK Clinical Trials Unit, (CRCTU) University of Birmingham.
Pam's main research interest is childhood acute leukaemias, specifically the development of new therapeutic approaches for this poor prognosis group. Her research is focused on the development of pre-clinical models for evaluation of new drugs and her clinical research is focused on the design and development of early phase clinical trials investigating novel therapies for childhood leukaemias.
Pam is a member of the NCRI Children's Cancer and Leukaemia Clinical Study Group and the associated New Agents Sub-Group. On a European level she is on the Executive Committee and the Clinical Trials Committee of the ITCC (Innovative Therapeutics for Children with Cancer), which is the European Consortium for drug development in children cancers and leukaemia.
Pam also co-founded the I-BFM Early Clinical Trials Committee and is a Co-investigator in the EU FP7 funded initiative; 'European Network for Cancer Research in Children and Adolescents' (ENCCA).